( It has been suggested that the next pa...)New influenza vaccine takes weeks to mass produce

"It has been suggested that the next pandemic strain may be derived from H5, H7, H9 or H2 influenza viruses. The preparation of the recombinant baculoviruses for the production of these antigens and the successful purifications gives us a great advantage in fighting against a potential influenza pandemic, if it derived from any of these strains," says Wang. "Starting from a stocked recombinant baculovirus bank, a closely matched vaccine can be massively produced within 2 weeks."

PSC has recently signed a Letter of Intent which will support commercial scale manufacturing with the capacity to produce 6 Million doses of monovalent pandemic vaccine per week.

'"/>

Source:American Society for Microbiology


Page: 1 2
Related biology news :

1. Computers to be used to find blueprint for new influenza drug
2. Less virulent strains of avian influenza can infect humans
3. Drug resistant avian influenza viruses more common in Southeast Asia than North America
4. New vaccine platform may fight infections with causes from influenza to bioterrorism
5. First big influenza genome study reveals flu evolution
6. Web model of influenza-host lifecycles will aid scientists in creating anti-viral drugs
7. Study outlines genetic differences between potential pandemic influenza strains
8. Avian influenza virus in mammals spreads beyond the site of infection to other organ systems
9. How can we protect patients with weakened immune systems from influenza?
10. Mouse study reveals new clues about virulence of 1918 influenza virus
11. Molecular anatomy of influenza virus detailed